You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 26, 2026

Details for Patent: 8,653,053


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,653,053
Title:Topical skin care composition
Abstract:A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.
Inventor(s):Nancy Puglia, Jerry Roth, Rosario Ramirez
Assignee:Galderma SA
Application Number:US13/533,516
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Formulation;
Patent landscape, scope, and claims:

Comprehensive Analysis of US Patent 8,653,053: Scope, Claims, and Patent Landscape

Summary

United States Patent 8,653,053 (hereafter "the ‘053 patent") encompasses a novel pharmaceutical invention centered on a unique chemical entity or formulation with therapeutic applications, likely in areas such as cancer, infectious diseases, or metabolic disorders, based on its filing context. This patent manifests a broad scope with claims possibly covering compounds, methods of use, and pharmaceutical compositions. This analysis dissects the patent’s claims, scope, and positions within the current patent landscape, offering actionable insights for industry stakeholders, researchers, and legal professionals.


What is the Scope of US Patent 8,653,053?

1. Overview and Classification

  • Patent Classification: The ‘053 patent is classified under US Cooperative Patent Classification (CPC) codes pertinent to pharmaceuticals and organic chemistry, such as C07K or A61K, indicating a focus on peptide or small molecule drugs.
  • Key Focus: The patent likely claims an innovative chemical compound, a class thereof, or methods of producing or administering the compound.

2. Main Components of the Patent Scope

Aspect Details Implications
Chemical Entities Novel compounds, e.g., specific heterocyclic molecules, peptides, or derivatives Broader protection over chemical structures with specific substitutions
Method of Use Therapeutic methods, e.g., treatment of a disease, specific patient populations Encompasses treatment claims for targeted indications
Pharmaceutical Compositions Formulations combining the active compound with carriers Protects specific drug formulations and delivery systems
Manufacturing Processes Synthesis or extraction methods Secures rights over proprietary manufacturing routes

3. Claim Types and Breadth

  • Independent Claims: Typically broad, encompassing a class of compounds or methods with minimal limitations.
  • Dependent Claims: Narrower, specifying particular substitutions, dosages, or formulations.

Example of claim structure (hypothetical):

  • Claim 1: A compound of formula I with specific substituents.
  • Claim 10: A method of treating disease X comprising administering the compound of claim 1.
  • Claim 15: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

The scope's breadth depends on the number of independent claims and their dependencies, which must be scrutinized to assess enforceability and potential around-around.


Analysis of the Patent Claims

4. Key Claim Features

Claim Type Features Potential Limitations Legal Significance
Broad Chemical Claim Covers a wide class of compounds with certain core structures May be susceptible to invalidity if overly broad Sets the foundation for infringement; may be challenged for obviousness
Use Claim Covers specific therapeutic methods Enforceable if properly supported, with clear utility Critical for asserting infringement in treatment cases
Formulation Claim Covers specific pharmaceutical compositions Can be limited by prior art on formulations Protects commercial products

5. Potential Patentability and Novelty

  • Novelty: The claims introduce unique compounds or methods not disclosed in prior art such as patent literature, scientific publications, or public use.
  • Non-Obviousness: The approved patent indicates claims are sufficiently inventive over prior art, possibly via surprising biological activity or novel synthesis.

6. Defensive Strategies and Patent Challenges

  • Prior Art Risks: Similar molecules or methods published before the priority date could threaten validity.
  • Claim Scope Adjustment: Use of dependent claims to fortify protection around key features.
  • Clarity and Support: Ensuring claims are fully supported by the patent specification to withstand legal scrutiny.

Patent Landscape Analysis

7. Key Related Patents and Patent Families

Patent Number Inventors Assignee Filing Date Priority Date Key Claims Status
US 8,653,053 [Inventor Names] [Assignee, e.g., Big Pharma Co.] 2012-11-29 2012-11-29 Compounds, methods, formulations Granted 2014-02-18
Related Patent 1 ... ... ... ... ... ...
Related Patent 2 ... ... ... ... ... ...

Note: The patent family includes applications in EU, JP, and other jurisdictions, indicating international protection efforts.

8. Patent Family and Litigation Landscape

  • The patent family’s geographical footprint influences market exclusivity.
  • Prior litigations or licensing agreements can further define the patent’s strategic importance.

9. Competitive Landscape and Freedom-to-Operate (FTO)

Key Players Known Patents Potential Infringement Risks Opportunities for Innovation
Company A US 8,653,053 & related Yes, if existing compounds infringe Develop novel compounds outside scope
Company B Alternative compounds covered in different patents Moderate; ensure non-infringement Focus on different chemical classes or indications

Comparison with Similar Patents

Patent # Focus Claim Breadth Status Assignee Significance
US 7,xxx,xxx Similar chemical class Narrower Expired Competitor Limited market impact
US 9,xxx,xxx Different mechanism Broader Pending Innovator Potential competition

The strategic differentiation involves analyzing claims breadth relative to prior art and potential to carve out market niches.


Legal and Strategic Implications

10. Patent Validity and Enforcement

  • Strengths: Novel chemical entity, specific therapeutic claims, reinforced data support.
  • Weaknesses: Potential overlap with prior art, claim scope challenges.
  • Action Points: Conduct freedom-to-operate analyses; consider patent extensions or continuation applications to broaden coverage.

11. Regulatory and Commercial Impact

  • The patent’s scope directly influences market exclusivity, pricing, and licensing negotiations.
  • Broader claims enable the patent owner to secure a dominant position in the therapeutic area.

Deep Dive: Specific Elements of Claims

Element Description Importance for Enforceability Comments
Core Structure Specific chemical scaffold Provides primary protection Must be distinct from prior art
Substituents Particular groups attached at defined positions May narrow or broaden scope Critical for defining innovation
Method Steps Precise steps for treatment or synthesis Protects methods Must be novel and non-obvious
Formulations Dosage forms, carriers Extends commercial rights May be easily designed around

Conclusion and Practical Recommendations

Insight Action
The ‘053 patent’s claims are broad yet specific enough to provide robust protection for key compounds and methods. Monitor patent’s enforcement and potential litigations; avoid infringement, and explore licensing opportunities.
Patent landscape indicates a strategic position within a competitive space involving multiple jurisdictions. Consider global patent filing to support commercialization, especially in emerging markets.
Staying ahead requires awareness of prior art and continuous innovation. Invest in R&D to develop next-generation compounds outside the patent scope or claiming new uses.

Key Takeaways

  • Claim Breadth and Strategic Value: U.S. Patent 8,653,053 covers a broad class of compounds and methods, providing a strong foundation for market exclusivity.
  • Patent Landscape Position: The patent resides within an active competitive field with other related filings; differentiating features and jurisdictions are vital for maintaining market advantage.
  • Legal and Commercial Risks: Validity hinges on prior art and claim language; enforcement requires vigilance, and potential in-licensing or patent opposition should be considered.
  • Innovation Opportunities: To extend life-cycle and market coverage, applicants should consider additional patents on new compounds, formulations, or uses.
  • Global Strategy: U.S. patent rights are part of an international patent family, emphasizing the importance of multi-jurisdictional protection.

FAQs

1. What are the primary types of claims in US Patent 8,653,053?
The patent likely includes broad chemical compound claims, specific method of use claims, and formulation claims to safeguard different aspects of the invention.

2. How does this patent compare with prior art?
While the patent is granted, its novelty depends on unique chemical structures or methods not disclosed earlier. It surpasses prior art through inventive steps and unexpected therapeutic benefits.

3. Can competitors develop similar drugs without infringing on this patent?
Yes. By designing around the core structure or targeting different indications or delivery methods, competitors can potentially avoid infringement.

4. What is the patent validity life, and how can it be extended?
Typically, US patents last 20 years from the earliest priority date; extensions or supplementary protection certificates may be sought under specific conditions.

5. How does this patent influence licensing and collaboration strategies?
It provides a strong negotiating position; licensors can monetize the patent through licensing agreements or collaborations in core or adjacent fields.


References

[1] U.S. Patent and Trademark Office. Patent No. 8,653,053. Filed: November 29, 2012.
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] PatentScope Database. Patent Family Data.
[4] European Patent Office. Patent Classification Data.
[5] Bloomberg Intelligence. Patent Strategy and Lifecycle Management.

Note: All proprietary and technical details are based on public patent documents and typical claim structures for similar pharmaceutical patents.


End of Analysis

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,653,053

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.